Vegetable Fat May Reduce Prostate Cancer Mortality

Share this article:
Switch to Vegetable Fat May Cut Death Risk in Prostate Cancer
Switch to Vegetable Fat May Cut Death Risk in Prostate Cancer

For men with non-metastatic prostate cancer, the risks of lethal prostate cancer and all-cause mortality are significantly reduced with replacement of carbohydrates by vegetable fats, according to a study published in JAMA Internal Medicine.

Erin L. Richman, Sc.D., from the University of California in San Francisco, and colleagues conducted a prospective study involving 4,577 men with non-metastatic prostate cancer to examine the correlation between post-diagnostic fat intake and outcomes (lethal prostate cancer and all-cause mortality).

During a median follow-up of 8.4 years, the researchers identified 315 lethal cancer events (distant metastases or prostate cancer-specific death) and 1,064 deaths. The risks of lethal prostate cancer and all-cause mortality were significantly reduced with replacement of 10 percent of energy intake from carbohydrate with vegetable fat (hazard ratios, 0.71 and 0.74, respectively). No association was seen with other fats and lethal prostate cancer. Higher all-cause mortality was seen with an increase in saturated and trans fats after diagnosis (replacement of 5 and 1 percent of energy from carbohydrates, respectively), with hazard ratios of 1.30 and 1.25, respectively.

"In conclusion, among men with non-metastatic prostate cancer, replacing carbohydrates and animal fat with vegetable fat may reduce the risk of all-cause mortality," the authors write. "The potential benefit of vegetable fat consumption for prostate cancer-specific outcomes merits further research."

This article originally appeared here.
Share this article:
You must be a registered member of RUN to post a comment.
close

Next Article in Prostate Cancer

More in Prostate Cancer

Prostate Cancer Adherence to Quality of Care Measures Frequently Low

Prostate Cancer Adherence to Quality of Care Measures ...

Regional variation seen in pretreatment counseling, overuse of bone scans, oncologist follow-up.

Prostate Brachytherapy On the Decline

Prostate Brachytherapy On the Decline

Use of this treatment for localized prostate cancer has been decreasing since 2002, perhaps due to increasing use of radical prostatectomy.

Adding ADT to Radiotherapy Improves Prostate Cancer Outcomes

Adding ADT to Radiotherapy Improves Prostate Cancer Outcomes

The combined treatment was associated with a reduced risk of biochemical and clinical progression compared with radiotherapy alone.